PARG1 抗体 (AA 301-400) (Cy7)
Quick Overview for PARG1 抗体 (AA 301-400) (Cy7) (ABIN762407)
抗原
See all PARG1 (ARHGAP29) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 301-400
-
交叉反应
- 人
-
预测反应
- Mouse,Rat,Dog,Cow,Pig,Horse,Rabbit
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human PARG1
-
亚型
- IgG
-
-
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- PARG1 (ARHGAP29) (rho GTPase Activating Protein 29 (ARHGAP29))
-
别名
- Rho GTPase activating protein 29
-
背景
-
Synonyms: PARG1, Rho GTPase-activating protein 29, PTPL1-associated RhoGAP protein 1, Rho-type GTPase-activating protein 29, ARHGAP29
Background: GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. Has strong activity toward RHOA, and weaker activity toward RAC1 and CDC42. May act as a specific effector of RAP2A to regulate Rho. In concert with RASIP1, suppresses RhoA signaling and dampens ROCK and MYH9 activities in endothelial cells and plays an essential role in blood vessel tubulogenesis.
-
基因ID
- 9411
-
UniProt
- Q52LW3
抗原
-